Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Zhejiang Huahai Pharmaceutical had revenue of 2.37B CNY in the quarter ending March 31, 2025, a decrease of -5.21%. This brings the company's revenue in the last twelve months to 9.42B, up 7.65% year-over-year. In the year 2024, Zhejiang Huahai Pharmaceutical had annual revenue of 9.55B with 14.91% growth.

• Revenue (ttm): 9.42B
• Revenue Growth: +7.65%
• P/S Ratio: 3.06
• Revenue / Employee: 1.04M
• Employees: 9,065
• Market Cap: 28.81B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.55B	1.24B	14.91%
Dec 31, 2023	8.31B	42.97M	0.52%
Dec 31, 2022	8.27B	1.62B	24.42%
Dec 31, 2021	6.64B	158.36M	2.44%
Dec 31, 2020	6.49B	1.10B	20.36%